Kansai Plus Atrial Fibrillation Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2113 participants.

Also called NCT01477983

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,113 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01477983
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01477983. Randomized; no masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2017-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Kansai Plus Atrial Fibrillation Trial
Acronym
KPAF
Intervention (Procedure)
ATP guide additional ablation.
Intervention (Drug)
Antiarrhythmic drug (AAD)
Intervention (Procedure)
ATP guide additional ablation.
Intervention (Drug)
Control
Intervention (Procedure)
Control
Intervention (Drug)
Antiarrhythmic drug (AAD)
Intervention (Procedure)
Control
Intervention (Drug)
Control
Lead sponsor
Kyoto University, Graduate School of Medicine (class: other)

Record details

Record id
cardio:ct-nct01477983
Content hash
200fc1c0cdafdbd0b0401a6c60410df50ed503ee9e414da21aea9f7eb759806a